GL1X · GenesisL1 explorer

MolNFT v1 · #156713 · protein

Crystal structure of human ppargamma ligand binding domain in complex with GW9662 and arachidonic acid

6MD2 · Peroxisome proliferator-activated receptor gamma: “Crystal structure of human ppargamma ligand binding domain in complex with GW9662 and arachidonic acid”. X-ray diffraction, 2 ligands (GW9, ACD), 9 pockets (best druggability 0.81).…

PDB
6MD2
Type
protein
Length
512 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
GW9, ACD
Pockets
9 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25569% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25767% helix, 5% strandP37231

Ligands and binding sites

  • GW9 · 2-chloro-5-nitro-N-phenylbenzamide · ligand · 2 copies · chains A, B
  • ACD · Arachidonic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18290.810.8373GW9, ACD
25230.800.8650GW9, ACD
31380.590.8420empty
41000.570.8619empty
52250.510.7625empty

Interfaces

1 interface between chains.

  • A–B · 928 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6MD2 · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.